DAS Health Ventures Announces Majority Sale to Coalesce Capital

Deal News | May 28, 2025 | Sheridan Capital Partners LLC

In an important financial maneuver, Sheridan Capital Partners has announced the sale of the majority stake of DAS Health Ventures, LLC to Coalesce Capital. This transaction marks a significant moment in Sheridan’s strategic partnership with DAS Health, a company specializing in healthcare IT and business solutions since 2021. Despite the sale, Sheridan will maintain a minority position in DAS Health, indicating ongoing involvement and potential future collaborations. The move is in line with Sheridan's strategic decisions to optimize its investment portfolio and capitalize on the growth and operational success of DAS Health under its stewardship. Coalesce Capital now takes on a significant role in DAS Health's future direction and operations, which may include further expansion or integration strategies in the healthcare IT sector.

Sectors

  • Private Equity
  • Healthcare IT
  • Business Solutions

Geography

  • United States – Sheridan Capital Partners is based in Chicago, IL, and the transaction involves a U.S. company, DAS Health.

Industry

  • Private Equity – Sheridan Capital Partners is a private equity firm involved in the transaction by selling a majority stake in DAS Health.
  • Healthcare IT – DAS Health provides healthcare IT and business solutions, indicating its sectoral involvement in this industry.
  • Business Solutions – DAS Health also offers business solutions, which reflects its operational focus apart from Healthcare IT.

Financials

  • Not Disclosed – The financial terms of the majority sale of DAS Health have not been disclosed.

Participants

NameRoleTypeDescription
Sheridan Capital Partners LLCSelling Company (Vendor)CompanyA private equity firm based in Chicago, involved in the sale of DAS Health.
DAS Health Ventures, LLCTarget CompanyCompanyA provider of healthcare IT and business solutions, being sold to Coalesce Capital.
Coalesce CapitalBuying Company (Buyer)CompanyThe company acquiring a majority stake in DAS Health Ventures.